Biosimilar developers should expect case-by-case evaluations, as the draft offers no hard rules on when CES will be waived. Developers are encouraged to consult the FDA early to understand evidentiary ...
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining ...
Learn about an effective immobilization method for membrane proteins, enhancing surface plasmon resonance techniques in research.
Research led by the University of Washington reports on an AI-guided method that designs epitope-specific antibodies and ...
To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T persistence and function. Additionally, there is a growing trend towards ...
From this core mechanism Fc engineering has evolved over time into the "engine" of therapeutic antibody development. It enables precise modulation of immune effector functions, optimization of ...
13d
Integral Molecular's Membrane Proteome Array(TM) Nears FDA Qualification as a Drug Development Tool
MPA on track to become the first NAM approved by the FDA for specificity testing PHILADELPHIA, /PRNewswire/ -- Integral Molecular, a leader in antibody discovery and characterization, announces that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback